Tranirus-ET Tablet

Overview Tranirus-ET Tablet

Hemostop-CX tablets combine medications to manage abnormally heavy menstrual flow. This treatment inhibits clot breakdown, thus controlling excessive bleeding by enhancing platelet aggregation and clot formation. Dosage and timing are flexible—with or without food—but daily consistency is recommended. Continue as directed by your physician; missed doses should be taken promptly. Complete the prescribed course, regardless of symptom improvement; abrupt cessation requires medical consultation. Common side effects include nausea, abdominal discomfort, headache, nasal stuffiness, sinusitis, skin rash, fatigue, and musculoskeletal pain. Diarrhea is possible; increased fluid intake is advised to prevent dehydration. Consult your doctor if bleeding patterns don't improve after three consecutive cycles. Prior to use, inform your physician of any kidney issues, vaginal bleeding disorders, pregnancy, breastfeeding, or other medications you're currently using. Regular eye examinations may be requested during treatment.

Uses of Tranirus-ET Tablet

Profound menstrual hemorrhage

Major Benefits of Tranirus-ET Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Tranirus-ET Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While Tranirus-ET Tablets can be taken with or without food, consistent timing is recommended.

Common Side effects of Tranirus-ET Tablet:

• Nausea
• Stomach pain
• Diarrhea
• Headache
• Nasal congestion (stuffy nose)
• Sinus pain
• Sinus inflammation
• Rash
• Tiredness
• Musculoskeletal (bone, muscle or joint) pain
• Anemia (low number of red blood cells)

How to use Tranirus-ET Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Tranirus-ET Tablets can be administered with or without food, although consistent timing is recommended.

How Tranirus-ET Tablet works:

Tranexamic acid and ethamsylate, combined as Tranirus-ET tablets, offer a dual approach to hemostasis. Tranexamic acid, an antifibrinolytic agent, stabilizes existing blood clots by inhibiting their dissolution, thus managing excessive blood loss. Ethamsylate, a hemostatic medication, enhances platelet aggregation, facilitating clot formation and controlling bleeding, particularly from capillary vessels.

What if you forget to take Tranirus-ET Tablet :

Should you forget a Tranirus-ET Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.